Advertisement
Combination therapy may help address underlying disease
Major study demonstrates importance of having a multidisciplinary approach to treatment for large, locally advanced tumors
Highly personalized treatment shrinks tumors resistant to immunotherapy
Best practices for reducing toxicities
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Highlighting treatment gaps and challenges in the management of rare condition
Explaining common misconceptions about chimeric antigen receptor therapy
Slower drug elimination from the body among females may impact safety and efficacy
Partnerships with local social service agencies key to program success
Study examines modifiable determinants of health disparities
Findings may guide future research and personalized treatments
Advertisement
Advertisement